Intrapartum Electronic Foetal Monitoring : Does it Lead or Mislead?

Vardhan, Shakti; Tk, Bhattacharyya; Kathpalia, SK; Kochar, Sps

doi:10.1016/s0377-1237(06)80157-7

Cited by 3 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 Potential reasons why cardiotocography has failed to fulfill its potential include erroneous interpretation, interobserver variation, and a lack of standardized guidelines. 2,5,6 Cardiotocography has high sensitivity, limited specificity, and a 60% false-positive rate. 7,8 Consequently, a normal cardiotocography result is reassuring but abnormal cardiotocography patterns do not offer definitive evidence of fetal hypoxia and/or acidosis.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A cross‐sectional comparison of three guidelines for intrapartum cardiotocography

Bhatia

Mahtani

Nunan

et al. 2017

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

“…Potential reasons why cardiotocography has failed to fulfill its potential include erroneous interpretation, interobserver variation, and a lack of standardized guidelines . Cardiotocography has high sensitivity, limited specificity, and a 60% false‐positive rate .…”

Section: Introductionmentioning

confidence: 99%

A cross‐sectional comparison of three guidelines for intrapartum cardiotocography

Bhatia

Mahtani

Nunan

et al. 2017

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

“…3 A nonreassuring trace occurs in up to 50% of all recordings but only a small proportion of these fetuses are at risk of hypoxia. 4 Clinical outcome of fetal distress can be assessed by Apgar score, umbilical artery PH, neonatal encephalopathy, perinatal death and cerebral palsy which have been used in isolation or in combination.…”

mentioning

confidence: 99%

Abnormal cardiotocographic findings and perinatal outcome: a prospective study

Sen¹,

Samal²,

Datta

et al. 2019

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: CTG as an intrapartum fetal surveillance can be judged appropriately taking the abnormal features of CTG individually into account for decision making of early delivery to reduce the fetal and neonatal morbidity. Objectives of this study were to identify the fetuses at risk of developing hypoxia as evidenced by abnormal FHR pattern seen by CTG and to correlate the abnormal features with perinatal outcome and find out the most specific feature among all abnormal features of CTG in detecting the adverse perinatal outcome.Methods: This was an observational study where total of 249 uncomplicated pregnant patients in active labor were selected randomly and CTG were done for them. Progress of labor was recorded in partogram. Only pathological CTGs were considered for early decision of delivery by LSCS. After delivery Apgar score 1 min, 5 min, baby weight, colour of liquor, NICU admission and no of days of admission in NICU were recorded.Results: For liquor colour, variability and absence of acceleration were good screening heart rate features and baseline was considered the most specific feature. For all babies with poor Apgar score at 1 min, abnormal baseline was the most specific feature. For NICU admission, the abnormal baseline the most specific feature. Acceleration was found to be the most sensitive heart rate feature among all other heart rate features. Liquor colour had better sensitivity for detecting poor Apgar score at 1min and 5 min. There was increase rate of cesarean section and operative vaginal delivery.Conclusions: Abnormal intrapartum CTG features of an uncomplicated laboring mother >37 weeks can detect fetuses at distress with different specificities and sensitivities when considered individually and can reduce the perinatal morbidity.

show abstract

“…Fetal monitors provide satisfactory and accurate monitoring of the heartbeat of the fetus and contractions of the uterus. The pattern of the fetus’s heart beat usually reflects its health [ 2 ]. The collected pattern data may be used to determine the status of the fetus during the prenatal stage or during the birth process.…”

Section: Introductionmentioning

confidence: 99%

A Mobile Multi-Agent Information System for Ubiquitous Fetal Monitoring

Chu

2014

IJERPH

View full text Add to dashboard Cite

Electronic fetal monitoring (EFM) systems integrate many previously separate clinical activities related to fetal monitoring. Promoting the use of ubiquitous fetal monitoring services with real time status assessments requires a robust information platform equipped with an automatic diagnosis engine. This paper presents the design and development of a mobile multi-agent platform-based open information systems (IMAIS) with an automated diagnosis engine to support intensive and distributed ubiquitous fetal monitoring. The automatic diagnosis engine that we developed is capable of analyzing data in both traditional paper-based and digital formats. Issues related to interoperability, scalability, and openness in heterogeneous e-health environments are addressed through the adoption of a FIPA2000 standard compliant agent development platform—the Java Agent Development Environment (JADE). Integrating the IMAIS with light-weight, portable fetal monitor devices allows for continuous long-term monitoring without interfering with a patient’s everyday activities and without restricting her mobility. The system architecture can be also applied to vast monitoring scenarios such as elder care and vital sign monitoring.

show abstract

Intrapartum Electronic Foetal Monitoring : Does it Lead or Mislead?

Cited by 3 publications

References 17 publications

A cross‐sectional comparison of three guidelines for intrapartum cardiotocography

A cross‐sectional comparison of three guidelines for intrapartum cardiotocography

Abnormal cardiotocographic findings and perinatal outcome: a prospective study

A Mobile Multi-Agent Information System for Ubiquitous Fetal Monitoring

Contact Info

Product

Resources

About